Please login to the form below

Not currently logged in
Email:
Password:

methylphenidate

This page shows the latest methylphenidate news and features for those working in and with pharma, biotech and healthcare.

Teva will have to endure revenue 'trough' in 2019

Teva will have to endure revenue 'trough' in 2019

Meanwhile, generic sales were down 10% to $1.1bn in North America, mainly due to competition for Teva’s authorised generic of Janssen’s attention-deficit hyperactivity disorder drug Concerta (methylphenidate),

Latest news

  • UCB's $1.53bn generics sale falls through UCB's $1.53bn generics sale falls through

    formulation of methylphenidate hydrochloride for attention-deficit hyperactivity disorder (ADHD). ... While we are working on clarifying the situation around methylphenidate ER we will continue the divestiture process for Kremers Urban," said UCB chief

  • J&J earnings leap on buoyant pharma sales J&J earnings leap on buoyant pharma sales

    On the downside, generic competition continued to take its toll on older drugs such as gastrointestinal Aciphex/Pariet (rabeprazole) and attention-deficit hyperactivity disorder drug Concerta (methylphenidate).

  • Buoyant pharma sales drive J&J's Q3 results Buoyant pharma sales drive J&J's Q3 results

    On the downside, attention-deficit hyperactivity disorder (ADHD) treatment Concerta (methylphenidate) continued to succumb to generic competition, losing $110m in sales compared to the third quarter of 2012 to come in

  • Pay-for-delay deals lead to inflated drug prices says study Pay-for-delay deals lead to inflated drug prices says study

    In the absence of Adderall XR, the price of rival ADHD brand Concerta (methylphenidate) from Johnson &Johnson would be around 5 per cent higher - at $101 per month instead of

  • Think positive: the rise of 'smart drugs' Think positive: the rise of 'smart drugs'

    which are reported with both methylphenidate and modafinil, says Mehta, who freely admits this hypothesis is untested. ... And with decades of experience with methylphenidate and modafinil there does not seem to be any major health issues surrounding

More from news
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • Challenging perceptions Challenging perceptions

    These classes were methylphenidate-based products like Johnson &Johnson's Concerta (methylphenidate hydrochloride) and Lilly's non-stimulant Strattera (atomoxetine).

  • Pharma deals during October 2012 Pharma deals during October 2012

    Established products – new formulations. Pfizer's acquisition of NextWave Pharmaceuticals bolsters its established products business unit bringing Quillivant XR (methylphenidate hydrochloride), which recently secured FDA approval for attention

  • Through the looking glass

    In mid-2009, Shire acquired EQUASYM XL (methylphenidate) for the treatment of childhood attention-deficit hyperactivity disorder (ADHD).

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics